Home/Novartis/Elizabeth (Liz) Doherty
E(

Elizabeth (Liz) Doherty

Board Member

Novartis

Novartis Pipeline

DrugIndicationPhase
Cosentyx®Pediatric Hidradenitis Suppurativa (12+)Approved
Pan-mutant-selective PI3Kα inhibitorBreast CancerAcquisition